SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Brandon L. Guthrie, Andrea Introini, Alison C. Roxby, Robert Y. Choi, Rose Bosire, Barbara Lohman-Payne, Taha Hirbod, Carey Farquhar, Kristina Broliden, Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1–Uninfected Women, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015, 69, 1, 1

    CrossRef

  2. 2
    Rebecca Pellett Madan, Lindi Masson, Jessica Tugetman, Lise Werner, Anneke Grobler, Koleka Mlisana, Yungtai Lo, Denise Che, Kelly B. Arnold, Salim S. Abdool Karim, Jo-Ann S. Passmore, Betsy C. Herold, Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition, AIDS Research and Human Retroviruses, 2015, 150714090348008

    CrossRef

  3. 3
    Marta Rodriguez Garcia, Mickey V. Patel, Zheng Shen, John V. Fahey, Nabanita Biswas, Jiri Mestecky, Charles R. Wira, Mucosal Immunology, 2015,

    CrossRef

  4. 4
    Anne C. Conibear, David J. Craik, Chemie und Biologie von Theta-Defensinen, Angewandte Chemie, 2014, 126, 40
  5. 5
    Danielle R. Fastring, Angela Amedee, Megan Gatski, Rebecca A. Clark, Leandro A. Mena, Judy Levison, Norine Schmidt, Janet Rice, Jeanette Gustat, Patricia Kissinger, Co-occurrence of Trichomonas vaginalis and Bacterial Vaginosis and Vaginal Shedding of HIV-1 RNA, Sexually Transmitted Diseases, 2014, 41, 3, 173

    CrossRef

  6. 6
    Andrea Introini, Tove Kaldensjö, Taha Hirbod, Maria Röhl, Annelie Tjernlund, Sonia Andersson, Kristina Broliden, Expression Profiles of Antimicrobial Peptides in the Genital Tract of Women Using Progesterone Intrauterine Devices Versus Combined Oral Contraceptives, American Journal of Reproductive Immunology, 2014, 72, 5
  7. 7
    Geert Van Raemdonck, Geert Zegels, Edmond Coen, Bea Vuylsteke, Wim Jennes, Xaveer Van Ostade, Increased Serpin A5 levels in the cervicovaginal fluid of HIV-1 exposed seronegatives suggest that a subtle balance between serine proteases and their inhibitors may determine susceptibility to HIV-1 infection, Virology, 2014, 458-459, 11

    CrossRef

  8. 8
    U M Abdel-Motal, C Harbison, T Han, J Pudney, D J Anderson, Q Zhu, S Westmoreland, W A Marasco, Prolonged expression of an anti-HIV-1 gp120 minibody to the female rhesus macaque lower genital tract by AAV gene transfer, Gene Therapy, 2014, 21, 9, 802

    CrossRef

  9. 9
    Praveen Rishi, Aman Preet Singh, Sumeha Arora, Neha Garg, Indu Pal Kaur, Revisiting eukaryotic anti-infective biotherapeutics, Critical Reviews in Microbiology, 2014, 40, 4, 281

    CrossRef

  10. 10
    Mimi Ghosh, Secreted Mucosal Antimicrobials in the Female Reproductive Tract that are Important to Consider for HIV Prevention, American Journal of Reproductive Immunology, 2014, 71, 6
  11. 11
    Madhuri Thakar, Rahul Patil, Subodh Shukre, Shubhangi Bichare, Poonam Kadam, Priyanka Khopkar, Manisha Ghate, Ramesh Paranjape, Short Communication: Genital Tumor Growth Factor-β1 Levels in HIV-Infected Indian Women Are Associated with Reduced Levels of Innate Antimicrobial Products and Increased HIV Shedding, AIDS Research and Human Retroviruses, 2014, 30, 7, 648

    CrossRef

  12. 12
    Anne C. Conibear, David J. Craik, The Chemistry and Biology of Theta Defensins, Angewandte Chemie International Edition, 2014, 53, 40
  13. 13
    Lindsay Aboud, Terry Blake Ball, Annelie Tjernlund, Adam Burgener, The Role of Serpin and Cystatin Antiproteases in Mucosal Innate Immunity and their Defense against HIV, American Journal of Reproductive Immunology, 2014, 71, 1
  14. 14
    Deborah J. Anderson, Jai Marathe, Jeffrey Pudney, The Structure of the Human Vaginal Stratum Corneum and its Role in Immune Defense, American Journal of Reproductive Immunology, 2014, 71, 6
  15. 15
    Pedro Mesquita, Betsy Herold, Drug Delivery and Development of Anti-HIV Microbicides, 2014,

    CrossRef

  16. 16
    C. M. Zumoffen, R. Gil, A. M. Caille, C. Morente, M. J. Munuce, S. A. Ghersevich, A protein isolated from human oviductal tissue in vitro secretion, identified as human lactoferrin, interacts with spermatozoa and oocytes and modulates gamete interaction, Human Reproduction, 2013, 28, 5, 1297

    CrossRef

  17. 17
    Azadeh Farzin, Pamela Boyer, Bonnie Ank, Karin Nielsen-Saines, Yvonne Bryson, Amniotic Fluid Exhibits an Innate Inhibitory Activity Against HIV Type 1 Replicationin Vitro, AIDS Research and Human Retroviruses, 2013, 29, 1, 77

    CrossRef

  18. 18
    Sarah S. Wilson, Mayim E. Wiens, Jason G. Smith, Antiviral Mechanisms of Human Defensins, Journal of Molecular Biology, 2013, 425, 24, 4965

    CrossRef

  19. 19
    S A Shukair, S A Allen, G C Cianci, D J Stieh, M R Anderson, S M Baig, C J Gioia, E J Spongberg, S M Kauffman, M D McRaven, H Y Lakougna, C Hammond, P F Kiser, T J Hope, Human cervicovaginal mucus contains an activity that hinders HIV-1 movement, Mucosal Immunology, 2013, 6, 2, 427

    CrossRef

  20. You have free access to this content20
    Huanbin Xu, Xiaolei Wang, Ronald S. Veazey, Mucosal immunology of HIV infection, Immunological Reviews, 2013, 254, 1
  21. 21
    Charles R. Wira, Marta Rodríguez-García, Mickey V. Patel, Sexually Transmitted Diseases, 2013,

    CrossRef

  22. 22
    Mohak Mhatre, Thomas McAndrew, Colleen Carpenter, Robert D. Burk, Mark H. Einstein, Betsy C. Herold, Cervical Intraepithelial Neoplasia Is Associated With Genital Tract Mucosal Inflammation, Sexually Transmitted Diseases, 2012, 39, 8, 591

    CrossRef

  23. 23
    Nannette Y. Yount, Michael R. Yeaman, Emerging Themes and Therapeutic Prospects for Anti-Infective Peptides, Annual Review of Pharmacology and Toxicology, 2012, 52, 1, 337

    CrossRef

  24. 24
    Karen W. Buckheit, Robert W. Buckheit, Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1, Molecular Biology International, 2012, 2012, 1

    CrossRef

  25. 25
    Brenna L. Anderson, Mimi Ghosh, Christina Raker, John Fahey, Yan Song, Dwight J. Rouse, Charles R. Wira, Susan Cu-Uvin, In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women, American Journal of Obstetrics and Gynecology, 2012, 207, 1, 65.e1

    CrossRef

  26. You have free access to this content26
    Esaki Muthu Shankar, Vijayakumar Velu, Ramachandran Vignesh, Sivakumar Vijayaraghavalu, Devi Velayuthan Rukumani, Negar Shafiei Sabet, Recent advances targeting innate immunity-mediated therapies against HIV-1 infection, Microbiology and Immunology, 2012, 56, 8
  27. You have free access to this content27
    Betsy C. Herold, Pedro M. Mesquita, Rebecca P. Madan, Marla J. Keller, Female Genital Tract Secretions and Semen Impact the Development of Microbicides for the Prevention of HIV and Other Sexually Transmitted Infections, American Journal of Reproductive Immunology, 2011, 65, 3
  28. 28
    Andrea R. Thurman, Gustavo F. Doncel, Innate Immunity and Inflammatory Response to Trichomonas vaginalis and Bacterial Vaginosis: Relationship to HIV Acquisition, American Journal of Reproductive Immunology, 2011, 65, 2
  29. You have free access to this content29
    Charles R. Wira, Mickey V. Patel, Mimi Ghosh, Lucy Mukura, John V. Fahey, Innate Immunity in the Human Female Reproductive Tract: Endocrine Regulation of Endogenous Antimicrobial Protection Against HIV and Other Sexually Transmitted Infections, American Journal of Reproductive Immunology, 2011, 65, 3
  30. You have free access to this content30
    Gustavo F. Doncel, Theresa Joseph, Andrea R. Thurman, Role of Semen in HIV-1 Transmission: Inhibitor or facilitator?, American Journal of Reproductive Immunology, 2011, 65, 3
  31. 31
    Hector Mendez-Figueroa, Brenna Anderson, Vaginal innate immunity: alteration during pregnancy and its impact on pregnancy outcomes, Expert Review of Obstetrics & Gynecology, 2011, 6, 6, 629

    CrossRef

  32. 32
    Georgina C Morris, Charles JN Lacey, Microbicides and HIV prevention: lessons from the past, looking to the future, Current Opinion in Infectious Diseases, 2010, 23, 1, 57

    CrossRef

  33. 33
    Laura Cascales, David J Craik, Naturally occurring circular proteins: distribution, biosynthesis and evolution, Organic & Biomolecular Chemistry, 2010, 8, 22, 5035

    CrossRef

  34. 34
    Sally A. Madsen-Bouterse, Roberto Romero, Adi L. Tarca, Juan Pedro Kusanovic, Jimmy Espinoza, Chong Jai Kim, Jung-Sun Kim, Samuel S. Edwin, Ricardo Gomez, Sorin Draghici, ORIGINAL ARTICLE: The Transcriptome of the Fetal Inflammatory Response Syndrome, American Journal of Reproductive Immunology, 2010, 63, 1
  35. 35
    Daniel Malamud, Sharon M Wahl, The mouth: a gateway or a trap for HIV?, AIDS, 2010, 24, 1, 5

    CrossRef

  36. 36
    John R. Mascola, David C. Montefiori, The Role of Antibodies in HIV Vaccines, Annual Review of Immunology, 2010, 28, 1, 413

    CrossRef

  37. 37
    P Pala, V R Gomez-Roman, J Gilmour, P Kaleebu, An African perspective on mucosal immunity and HIV-1, Mucosal Immunology, 2009, 2, 4, 300

    CrossRef

  38. 38
    Yongming Sang, Piotr Ruchala, Robert I. Lehrer, Chris R. Ross, Raymond R.R. Rowland, Frank Blecha, Antimicrobial Host Defense Peptides in an Arteriviral Infection: Differential Peptide Expression and Virus Inactivation, Viral Immunology, 2009, 22, 4, 235

    CrossRef

  39. 39
    G. Wang, X. Li, Z. Wang, APD2: the updated antimicrobial peptide database and its application in peptide design, Nucleic Acids Research, 2009, 37, Database, D933

    CrossRef

  40. 40
    Zhiguo Li, Allison Moy, Kirti Sohal, Carolyn Dam, Peter Kuo, James Whittaker, Mei Whittaker, Nejat Düzgünes, Krystyna Konopka, Andreas H. Franz, Joan Lin-Cereghino, Geoff P. Lin-Cereghino, Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris, Protein Expression and Purification, 2009, 67, 2, 175

    CrossRef

  41. 41
    Philip Lawrence, Aline Zimmer, Stéphane Paul, Infection muqueuse par le virus VIH-1: mécanismes, conséquences, perspectives de vaccination, Revue Francophone des Laboratoires, 2009, 2009, 410, 45

    CrossRef

  42. 42
    Catalin S Buhimschi, Margaret A Baumbusch, Katherine H Campbell, Antonette T Dulay, Irina A Buhimschi, Insight into innate immunity of the uterine cervix as a host defense mechanism against infection and preterm birth, Expert Review of Obstetrics & Gynecology, 2009, 4, 1, 9

    CrossRef

  43. 43
    K. Broliden, A. T. Haase, S. K. Ahuja, G. M. Shearer, J. Andersson, Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts, Journal of Internal Medicine, 2009, 265, 1
  44. 44
    Pauline Levinson, Rupert Kaul, Joshua Kimani, Elizabeth Ngugi, Stephen Moses, Kelly S MacDonald, Kristina Broliden, Taha Hirbod, Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition, AIDS, 2009, 23, 3, 309

    CrossRef

  45. 45
    Masaaki Miyazawa, Lucia Lopalco, Francesco Mazzotta, Sergio Lo Caputo, Francisco Veas, Mario Clerici, The ‘immunologic advantage’ of HIV-exposed seronegative individuals, AIDS, 2009, 23, 2, 161

    CrossRef

  46. 46
    K. Johan Rosengren, Norelle L. Daly, David J. Craik, 2009,

    CrossRef

  47. 47
    Thomas M Zydowsky, Microbicides: chemistry, structure, and strategy, Current Opinion in HIV and AIDS, 2008, 3, 5, 548

    CrossRef